MedTrace Logo

EVL Plus Drug to Prevent Variceal Rebleeding

NCT00371943 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2006-09-15

No results posted yet for this study

Summary

Both medications with beta-blockers and isosorbide-5-mononitrate and endoscopic variceal ligation have been proven plausible in the prevention of variceal rebleeding. However, the relative efficacy and safety of the combined treatment for preventing rebleeding remains unresolved.

Conditions

Interventions

PROCEDURE

band ligation

Sponsors & Collaborators

  • National Science and Technology Council, Taiwan

    lead OTHER_GOV

Principal Investigators

  • Gin Ho Lo · Kaohsiung Veterans General Hospital.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-07-31
Completion
2005-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00371943 on ClinicalTrials.gov